These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1745023)

  • 1. Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin A.
    Derfler K; Hayde M; Heinz G; Hirschl MM; Steger G; Hauser AC; Balcke P; Widhalm K
    Kidney Int; 1991 Oct; 40(4):720-7. PubMed ID: 1745023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postheparin lipolytic activity in acute and chronic renal failure.
    Gupta KL; Majumdar S; Sakhuja V
    Ren Fail; 1994; 16(5):609-15. PubMed ID: 7855316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective deficiency of hepatic triglyceride lipase and hypertriglyceridaemia in kwashiorkor.
    Agbedana EO; Johnson AO; Taylor GO
    Br J Nutr; 1979 Nov; 42(3):351-6. PubMed ID: 228697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postheparin lipolytic activity and plasma lipoprotein response to omega-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia.
    Nozaki S; Garg A; Vega GL; Grundy SM
    Am J Clin Nutr; 1991 Mar; 53(3):638-42. PubMed ID: 2000816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus.
    Ichimaru N; Takahara S; Kokado Y; Wang JD; Hatori M; Kameoka H; Inoue T; Okuyama A
    Atherosclerosis; 2001 Oct; 158(2):417-23. PubMed ID: 11583721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes).
    Brunzell JD; Porte D; Bierman EL
    Metabolism; 1975 Oct; 24(10):1123-37. PubMed ID: 1165728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
    Ibels SL; Reardon MF; Nestel PJ
    J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
    Morrisett JD; Abdel-Fattah G; Kahan BD
    Transplant Proc; 2003 May; 35(3 Suppl):143S-150S. PubMed ID: 12742487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein--postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals.
    Nozaki S; Kubo M; Sudo H; Matsuzawa Y; Tarui S
    Metabolism; 1986 Jan; 35(1):53-8. PubMed ID: 3941609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin).
    Brattström C; Wilczek H; Tydén G; Böttiger Y; Säwe J; Groth CG
    Transplantation; 1998 May; 65(9):1272-4. PubMed ID: 9603181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pindolol on serum lipoproteins and postheparin lipolytic activities in hypertensive patients.
    Sasaki N; Saito Y; Shinomiya M; Kanzaki T; Ishikawa Y; Mori S; Kobayashi J; Murano S; Nishide T; Morisaki N
    Clin Ther; 1990; 12(2):157-64. PubMed ID: 2354485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients.
    Blackhall ML; Fassett RG; Sharman JE; Geraghty DP; Coombes JS
    Nephrol Dial Transplant; 2005 Sep; 20(9):1970-5. PubMed ID: 15998657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A.
    Massy ZA; De Bandt JP; Morelon E; Thevenin M; Lacour B; Kreis H
    Nephrol Dial Transplant; 2000 Jun; 15(6):928. PubMed ID: 10831671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.